Ore Pharmaceutical Holdings Inc. is a pharmaceutical asset management company. We acquire interests in pharmaceutical assets whose value, we believe, we can significantly enhance through targeted development, with the goal of then monetizing these assets via sale or out-licensing. In order to fund these activities, we will source third-party financing using alternative investment vehicles designed to align the investment profile of each program with the interests of its direct investors as well as Ore shareholders. Our goal is to create an investment-driven, ROI-focused organization distinctly different from traditional research-intensive biotechnology companies.